Forma Therapeutics Holdings Inc

+0.84 (+4.78%)
Earnings Announcements

Forma Therapeutics Reports Qtrly Loss Per Share Of $0.68

Published: 03/30/2021 11:36 GMT
Forma Therapeutics Holdings Inc (FMTX) - Forma Therapeutics Reports Fourth Quarter and Year-end 2020 Financial Results and Provides Business Update.
Current Cash Runway is Projected Through Q3 of 2024.
Qtrly Loss per Share $0.68.
Q4 Earnings per Share View $-0.80 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.96

Next Quarter Revenue Guidance is expected to be $8.33 Million
Next Quarter EPS Guidance is expected to be -$0.85

More details on our Analysts Page.